Previous Article | Next Article ![]()
Infect. Immun., Jun 1995, 2221-2227, Vol 63, No. 6
J Ma, C Gingrich-Baker, PM Franchi, P Bulger and RT Coughlin
The neutralizing epitopes of the major outer surface proteins A and B (OspA
and OspB) of Borrelia burgdorferi B31 were investigated by epitope mapping
using overlapping synthetic peptides, encompassing full- length OspA and
OspB, and antiborrelial monoclonal antibodies (MAbs). OspA MAb N4B12 and
OspB MAbs N5G5, W7C2, and P4D1 displayed a complement-independent
antiborrelial activity, and complement failed to enhance the antiborrelial
activity, as measured by a sensitive colorimetric assay. A combination of
N4B12 with N5G5 displayed a higher antiborrelial activity than did the MAbs
individually. OspA MAbs B3G11 and L3B5, however, exhibited a significant
antiborrelial activity only in the presence of complement. Epitope mapping
showed that B3G11 bound to one OspA synthetic peptide with the sequence of
amino acids 247 to 256 (QYDSNGTKLE) and produced more than sixfold-higher
reactivity than with other sequences, as measured by an enzyme-linked
immunosorbent assay. OspB MAb N5G5 bound to an OspB peptide with the
sequence of amino acids 211 to 220 (TLKREIEKDG), yielding at least
threefold-higher reactivity than with other sequences. These two peptide
sequences were found to contain neutralizing epitopes. Other MAbs had weak
binding activities with the synthetic peptides, and their specific epitopes
remain to be further analyzed. Thus, this study demonstrated both
complement-independent and complement-dependent antiborrelial MAbs and
identified the linear epitopes on OspA and OspB capable of inducing
neutralizing antibody responses.
Copyright © 1995, American Society for Microbiology
Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi
Cambridge Biotech Corporation, Worcester, Massachusetts 01605, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|